Centogene N.V. (CNTGF)

Market Cap	2.98M
Revenue (ttm)	53.65M
Net Income (ttm)	-39.27M
Shares Out	29.82M
EPS (ttm)	-1.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	521
Open	0.1017
Previous Close	0.1000
Day's Range	0.1017 - 0.1017
52-Week Range	0.0100 - 0.7050
Beta	0.03
RSI	54.12
Earnings Date	Sep 5, 2025

About Centogene

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, i...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 384
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNTGF

Financial Performance

In 2023, Centogene's revenue was 48.54 million, an increase of 2.24% compared to the previous year's 47.47 million. Losses were -35.53 million, 11.6% more than in 2022.

Financial numbers in EUR